PhotonPharma Revenue and Competitors
Estimated Revenue & Valuation
- PhotonPharma's estimated annual revenue is currently $1.7M per year.
- PhotonPharma's estimated revenue per employee is $155,000
Employee Data
- PhotonPharma has 11 Employees.
- PhotonPharma grew their employee count by -8% last year.
PhotonPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder, CSO, VP Research and Development | Reveal Email/Phone |
PhotonPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 35 | 483% | $25M | N/A |
#2 | $2M | 13 | 18% | N/A | N/A |
#3 | $3.4M | 22 | 10% | N/A | N/A |
#4 | $68M | 439 | -3% | N/A | N/A |
#5 | $2M | 13 | 30% | N/A | N/A |
#6 | $4M | 26 | 8% | N/A | N/A |
#7 | $2.7M | 35 | -10% | $23.2M | N/A |
#8 | $5.3M | 34 | 70% | N/A | N/A |
#9 | $1.7M | 11 | -8% | N/A | N/A |
#10 | $3.1M | 20 | -17% | N/A | N/A |
What Is PhotonPharma?
PhotonPharma is an immuno-oncology company with a break-through technology that stimulates a patient’s own immune system to seek out and destroy their cancer cells. We have a patent protected process that precisely inactivates DNA/RNA of a patient’s own tumor cells while leaving the cells alive with all of unique tumor specific antigen targets (neoantigens) intact. The process is simple, fast and inexpensive. A patient’s tumor cells can be extracted, inactivated and administered back on the same day. Efficacy and safety has been demonstrated in a dog trial (companion animals) and in mouse studies.
keywords:N/A
N/A
Total Funding
11
Number of Employees
$1.7M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Fort Collins
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $1M | 12 | 9% | N/A |
#3 | $1M | 12 | N/A | N/A |
#4 | $1M | 12 | N/A | N/A |
#5 | $1M | 12 | -25% | N/A |